Abstract
Patients with melanoma who had one or more close relatives with melanoma were studied for their natural-killer-cell (NK) activity against cultured melanoma cells and Chang cells. A high proportion of the patients and their relatives were found to have low NK activity against these target cells. In most of the patients this could not be attributed to general depression of their immune function, since B- and T-cell numbers and the mitogenic response to PHA were within normal limits. The levels of NK activity of the patients and their relatives were found to be significantly correlated, suggesting that the NK activity in these families may have been genetically (or environmentally) determined. Several genetic markers were examined in the patients and their relatives for association with the disease state and NK activity. No association with HLA antigens or ABO blood groups was detected, but there was a low incidence of the Rhesus negative phenotype in the patients (the Rh phenotype had previously been associated with high NK activity). The present results indicate that NK activity has a familial association in families with a high incidence of melanoma, and raise the question whether low NK activity may be one of the predisposing factors in the development of familial melanoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Hersey, P., Edwards, A., Honeyman, M. et al. Low natural-killer-cell activity in familial melanoma patients and their relatives. Br J Cancer 40, 113–122 (1979). https://doi.org/10.1038/bjc.1979.147
Issue Date:
DOI: https://doi.org/10.1038/bjc.1979.147
This article is cited by
-
The use of natural killer cell activity and PPD test in the prediction of results in intravesical BCG treatment of patients with nonmuscle-invasive bladder cancer
International Urology and Nephrology (2022)
-
Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity
Cancer Immunology, Immunotherapy (2022)
-
Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy
Experimental & Molecular Medicine (2017)
-
NK cells and cancer: you can teach innate cells new tricks
Nature Reviews Cancer (2016)
-
Natural killer cell activity in patients with pernicious anemia
Digestive Diseases and Sciences (1995)